JANX
Price
$24.90
Change
-$0.66 (-2.58%)
Updated
Jun 13 closing price
Capitalization
1.47B
58 days until earnings call
MAIA
Price
$1.72
Change
-$0.03 (-1.71%)
Updated
Jun 13 closing price
Capitalization
52.93M
51 days until earnings call
Interact to see
Advertisement

JANX vs MAIA

Header iconJANX vs MAIA Comparison
Open Charts JANX vs MAIABanner chart's image
Janux Therapeutics
Price$24.90
Change-$0.66 (-2.58%)
Volume$374.34K
Capitalization1.47B
MAIA Biotechnology
Price$1.72
Change-$0.03 (-1.71%)
Volume$59.57K
Capitalization52.93M
JANX vs MAIA Comparison Chart
Loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JANX vs. MAIA commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and MAIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (JANX: $24.90 vs. MAIA: $1.72)
Brand notoriety: JANX and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 38% vs. MAIA: 21%
Market capitalization -- JANX: $1.47B vs. MAIA: $52.93M
JANX [@Biotechnology] is valued at $1.47B. MAIA’s [@Biotechnology] market capitalization is $52.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, both JANX and MAIA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 5 TA indicator(s) are bullish while MAIA’s TA Score has 3 bullish TA indicator(s).

  • JANX’s TA Score: 5 bullish, 4 bearish.
  • MAIA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, JANX is a better buy in the short-term than MAIA.

Price Growth

JANX (@Biotechnology) experienced а -5.00% price change this week, while MAIA (@Biotechnology) price change was -4.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

JANX is expected to report earnings on Aug 12, 2025.

MAIA is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.47B) has a higher market cap than MAIA($52.9M). MAIA YTD gains are higher at: -13.131 vs. JANX (-53.493). MAIA has higher annual earnings (EBITDA): -24.75M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. MAIA (10.9M). JANX has higher revenues than MAIA: JANX (9.34M) vs MAIA (0).
JANXMAIAJANX / MAIA
Capitalization1.47B52.9M2,784%
EBITDA-111.54M-24.75M451%
Gain YTD-53.493-13.131407%
P/E RatioN/AN/A-
Revenue9.34M0-
Total Cash1.01B10.9M9,303%
Total Debt22.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
JANXMAIA
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend about 1 month ago
86%
Bullish Trend 19 days ago
88%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFM157.920.88
+0.56%
Sprouts Farmers Market
BUD71.22-0.48
-0.67%
Anheuser-Busch INBEV SA/NV
DOMO13.04-0.65
-4.75%
Domo
SG12.58-0.66
-4.98%
Sweetgreen
RBOT7.92-0.78
-8.97%
Vicarious Surgical

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SKYE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-2.58%
SKYE - JANX
40%
Loosely correlated
-5.53%
CRNX - JANX
39%
Loosely correlated
-1.24%
KYMR - JANX
37%
Loosely correlated
-0.70%
IDYA - JANX
37%
Loosely correlated
-0.45%
APGE - JANX
37%
Loosely correlated
+6.26%
More

MAIA and

Correlation & Price change

A.I.dvisor tells us that MAIA and ARDX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAIA and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
-1.71%
ARDX - MAIA
29%
Poorly correlated
-3.23%
IPSC - MAIA
26%
Poorly correlated
-4.10%
JANX - MAIA
24%
Poorly correlated
-2.58%
XENE - MAIA
23%
Poorly correlated
-0.12%
TERN - MAIA
23%
Poorly correlated
-1.27%
More